{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T22:57:04Z","timestamp":1774565824579,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,28]]},"DOI":"10.7759\/cureus.29699","type":"journal-article","created":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T16:18:45Z","timestamp":1664381925000},"source":"Crossref","is-referenced-by-count":1,"title":["Management of Idiopathic Pulmonary Arterial Hypertension in a Patient in Trinidad: A Case Report"],"prefix":"10.7759","author":[{"given":"Nishtha","family":"Mohan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic","family":"Dalip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiva","family":"Jaggernauth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s12170-020-00663-3","article-title":"Management of pulmonary arterial hypertension","volume":"15","author":"Mayeux JD","year":"2021","unstructured":"Mayeux JD, Pan IZ, Dechand J, et al.. Management of pulmonary arterial hypertension. Curr Cardiovasc Risk Rep. 2021, 15:2. 10.1007\/s12170-020-00663-3","journal-title":"Curr Cardiovasc Risk Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13167-4","article-title":"Primary pulmonary hypertension","volume":"3","author":"Runo JR","year":"2003","unstructured":"Runo JR, Loyd JE. Primary pulmonary hypertension. Lancet. 2003, 3:1533-44. 10.1016\/S0140-6736(03)13167-4","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3329\/jemc.v1i2.11468","article-title":"Primary pulmonary hypertension: a case report","volume":"1","author":"Bhattacharjee S","year":"2012","unstructured":"Bhattacharjee S, Bhattacharjee S. Primary pulmonary hypertension: a case report. Journal of Enam Medical College. 2012, 1:81-84. 10.3329\/jemc.v1i2.11468","journal-title":"Journal of Enam Medical College"},{"key":"ref4","article-title":"Idiopathic Pulmonary Artery Hypertension","author":"Pahal P","year":"2022","unstructured":"Pahal P, Sharma S. Idiopathic Pulmonary Artery Hypertension. StatPearls Publishing, Treasure Island (FL); 2022. https:\/\/pubmed.ncbi.nlm.nih.gov\/29489262\/."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.10.029","article-title":"Updated clinical classification of pulmonary hypertension","volume":"62","author":"Simonneau G","year":"2013","unstructured":"Simonneau G, Gatzoulis MA, Adatia I, et al.. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013, 62:D34-41. 10.1016\/j.jacc.2013.10.029","journal-title":"J Am Coll Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-1246","article-title":"Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension","volume":"132","author":"Gan CT","year":"2007","unstructured":"Gan CT, Lankhaar JW, Westerhof N, et al.. Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension. Chest. 2007, 132:1906-12. 10.1378\/chest.07-1246","journal-title":"Chest"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/omcr\/omz073","article-title":"Pulmonary hypertension as a primary presentation for schistosomiasis, a case report of unusual presentation","volume":"2019","author":"Hussein MI","year":"2019","unstructured":"Hussein MI. Pulmonary hypertension as a primary presentation for schistosomiasis, a case report of unusual presentation. Oxf Med Case Reports. 2019, 2019:omz073. 10.1093\/omcr\/omz073","journal-title":"Oxf Med Case Reports"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ers guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"37","author":"Gali\u00e8 N","year":"2016","unstructured":"Gali\u00e8 N, Humbert M, Vachiery JL, et al.. 2015 ESC\/ers guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016, 37:67-119. 10.1093\/eurheartj\/ehv317","journal-title":"Eur Heart J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/2045-8932.101655","article-title":"The impact of pulmonary arterial hypertension-targeted therapy on survival in Chinese patients with idiopathic pulmonary arterial hypertension","volume":"2","author":"Zeng WJ","year":"2012","unstructured":"Zeng WJ, Sun YJ, Gu Q, Xiong CM, Li JJ, He JG. The impact of pulmonary arterial hypertension-targeted therapy on survival in Chinese patients with idiopathic pulmonary arterial hypertension. Pulm Circ. 2012, 2:373-8. 10.4103\/2045-8932.101655","journal-title":"Pulm Circ"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.10.031","article-title":"Updated treatment algorithm of pulmonary arterial hypertension","volume":"62","author":"Gali\u00e8 N","year":"2013","unstructured":"Gali\u00e8 N, Corris PA, Frost A, et al.. Updated treatment algorithm of pulmonary arterial hypertension. J Am Coll Cardiol. 2013, 62:D60-72. 10.1016\/j.jacc.2013.10.031","journal-title":"J Am Coll Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-3124","article-title":"High occurrence of hypoxemic sleep respiratory disorders in precapillary pulmonary hypertension and mechanisms","volume":"143","author":"Jilwan FN","year":"2013","unstructured":"Jilwan FN, Escourrou P, Garcia G, Ja\u00efs X, Humbert M, Roisman G. High occurrence of hypoxemic sleep respiratory disorders in precapillary pulmonary hypertension and mechanisms. Chest. 2013, 143:47-55. 10.1378\/chest.11-3124","journal-title":"Chest"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2017.01.015","article-title":"Survival of Japanese patients with idiopathic\/heritable pulmonary arterial hypertension","volume":"119","author":"Ogawa A","year":"2017","unstructured":"Ogawa A, Satoh T, Tamura Y, Fukuda K, Matsubara H. Survival of Japanese patients with idiopathic\/heritable pulmonary arterial hypertension. Am J Cardiol. 2017, 119:1479-84. 10.1016\/j.amjcard.2017.01.015","journal-title":"Am J Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension","volume":"334","author":"Barst RJ","year":"1996","unstructured":"Barst RJ, Rubin LJ, Long WA, et al.. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med. 1996, 334:296-301. 10.1056\/NEJM199602013340504","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-149-8-200810210-00004","article-title":"Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial","volume":"21","author":"Simonneau G","year":"2008","unstructured":"Simonneau G, Rubin LJ, Gali\u00e8 N, et al.. Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial. Ann Intern Med. 2008, 21:521-30.. 10.7326\/0003-4819-149-8-200810210-00004","journal-title":"Ann Intern Med"},{"key":"ref15","unstructured":"Remodulin. (2021). Accessed. November 03, 2021: https:\/\/ir.unither.com\/news\/press-releases\/press-release-details\/2021\/United-Therapeutics-Corporation-Reports-Third-Q...."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/2045894019878615","article-title":"Long-term results of the DelIVery for pulmonary arterial hypertension trial","volume":"9","author":"Gomberg-Maitland M","year":"2019","unstructured":"Gomberg-Maitland M, Bourge RC, Shapiro SM, et al.. Long-term results of the DelIVery for pulmonary arterial hypertension trial. Pulm Circ. 2019, 9:2045894019878615. 10.1177\/2045894019878615","journal-title":"Pulm Circ"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.186.11.1196","article-title":"A case series of patients with severe pulmonary hypertension receiving an implantable pump for intravenous prostanoid therapy","volume":"186","author":"Ewert R","year":"2012","unstructured":"Ewert R, Halank M, Bruch L, Ghofrani HA. A case series of patients with severe pulmonary hypertension receiving an implantable pump for intravenous prostanoid therapy. Am J Respir Crit Care Med. 2012, 186:1196-8. 10.1164\/ajrccm.186.11.1196","journal-title":"Am J Respir Crit Care Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1177\/2045894020907881","article-title":"Implantable system for treprostinil: a real-world patient experience study","volume":"10","author":"Shapiro S","year":"2020","unstructured":"Shapiro S, Bourge RC, Pozella P, Harris DF, Borg EH, Nelsen AC. Implantable system for treprostinil: a real-world patient experience study. Pulm Circ. 2020, 10:2045894020907881. 10.1177\/2045894020907881","journal-title":"Pulm Circ"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2015.11.005","article-title":"Treprostinil administered to treat pulmonary arterial hypertension using a fully implantable programmable intravascular delivery system: results of the delivery for PAH trial","volume":"150","author":"Bourge RC","year":"2016","unstructured":"Bourge RC, Waxman AB, Gomberg-Maitland M, et al.. Treprostinil administered to treat pulmonary arterial hypertension using a fully implantable programmable intravascular delivery system: results of the delivery for PAH trial. Chest. 2016, 150:27-34. 10.1016\/j.chest.2015.11.005","journal-title":"Chest"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.165.6.2106079","article-title":"Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial","volume":"165","author":"Simonneau G","year":"2002","unstructured":"Simonneau G, Barst RJ, Galie N, et al.. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med. 2002, 165:800-4. 10.1164\/ajrccm.165.6.2106079","journal-title":"Am J Respir Crit Care Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01889-2018","article-title":"Risk stratification and medical therapy of pulmonary arterial hypertension","volume":"53","author":"Gali\u00e8 N","year":"2019","unstructured":"Gali\u00e8 N, Channick RN, Frantz RP, et al.. Risk stratification and medical therapy of pulmonary arterial hypertension. Eur Respir J. 2019, 53:1801889. 10.1183\/13993003.01889-2018","journal-title":"Eur Respir J"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10153326","article-title":"Interventional and surgical treatments for pulmonary arterial hypertension","volume":"10","author":"St\u0105cel T","year":"2021","unstructured":"St\u0105cel T, Latos M, Urlik M, et al.. Interventional and surgical treatments for pulmonary arterial hypertension. J Clin Med. 2021, 10:10.3390\/jcm10153326","journal-title":"J Clin Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2011.00021","article-title":"Therapeutic strategies in pulmonary hypertension","volume":"2","author":"Fuso L","year":"2011","unstructured":"Fuso L, Baldi F, Di Perna A. Therapeutic strategies in pulmonary hypertension. Front Pharmacol. 2011, 2:21. 10.3389\/fphar.2011.00021","journal-title":"Front Pharmacol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0192100","article-title":"Correction: Lung and heart-lung transplantation in pulmonary arterial hypertension","volume":"13","author":"L\u00f3pez-Meseguer M","year":"2018","unstructured":"L\u00f3pez-Meseguer M, Quezada CA, Ramon MA, et al.. Correction: Lung and heart-lung transplantation in pulmonary arterial hypertension. PLoS One. 2018, 13:e0192100. 10.1371\/journal.pone.0192100","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00139009","article-title":"Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"34","author":"Gali\u00e8 N","year":"2009","unstructured":"Gali\u00e8 N, Hoeper MM, Humbert M, et al.. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2009, 34:1219-63. 10.1183\/09031936.00139009","journal-title":"Eur Respir J"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.5339\/gcsp.2014.25","article-title":"Anticoagulation in pulmonary arterial hypertension: contemporary data from COMPERA registry","volume":"2014","author":"Said K","year":"2014","unstructured":"Said K. Anticoagulation in pulmonary arterial hypertension: contemporary data from COMPERA registry. Glob Cardiol Sci Pract. 2014, 2014:48-52. 10.5339\/gcsp.2014.25","journal-title":"Glob Cardiol Sci Pract"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187811","article-title":"Lung and heart-lung transplantation in pulmonary arterial hypertension","volume":"12","author":"L\u00f3pez-Meseguer M","year":"2017","unstructured":"L\u00f3pez-Meseguer M, Quezada CA, Ramon MA, et al.. Lung and heart-lung transplantation in pulmonary arterial hypertension. PLoS One. 2017, 12:e0187811. 10.1371\/journal.pone.0187811","journal-title":"PLoS One"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.04.017","article-title":"Updated evidence-based treatment algorithm in pulmonary arterial hypertension","volume":"54","author":"Barst RJ","year":"2009","unstructured":"Barst RJ, Gibbs JS, Ghofrani HA, et al.. Updated evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol. 2009, 54:S78-84. 10.1016\/j.jacc.2009.04.017","journal-title":"J Am Coll Cardiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s41030-018-0052-z","article-title":"Volume management in pulmonary arterial hypertension patients: an expert pulmonary hypertension clinician perspective","volume":"4","author":"Hansen L","year":"2018","unstructured":"Hansen L, Burks M, Kingman M, Stewart T. Volume management in pulmonary arterial hypertension patients: an expert pulmonary hypertension clinician perspective. Pulm Ther. 2018, 4:13-27. 10.1007\/s41030-018-0052-z","journal-title":"Pulm Ther"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.12659\/msm.882607","article-title":"Treatment of pulmonary hypertension","volume":"18","author":"Patel R","year":"2012","unstructured":"Patel R, Aronow WS, Patel L, Gandhi K, Desai H, Kaul D, Sahgal SP. Treatment of pulmonary hypertension. Med Sci Monit. 2012, 18:RA31-9. 10.12659\/msm.882607","journal-title":"Med Sci Monit"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01906-2018","article-title":"Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension","volume":"53","author":"Hoeper MM","year":"2019","unstructured":"Hoeper MM, Benza RL, Corris P, et al.. Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension. Eur Respir J. 2019, 53:10.1183\/13993003.01906-2018","journal-title":"Eur Respir J"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau G","year":"2019","unstructured":"Simonneau G, Montani D, Celermajer DS, et al.. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019, 53:10.1183\/13993003.01913-2018","journal-title":"Eur Respir J"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2015.01.004","article-title":"The role of calcium channel blockers for the treatment of pulmonary arterial hypertension: How much do we actually know and how could they be positioned today?","volume":"109","author":"Medarov BI","year":"2015","unstructured":"Medarov BI, Judson MA. The role of calcium channel blockers for the treatment of pulmonary arterial hypertension: How much do we actually know and how could they be positioned today?. Respir Med. 2015, 109:557-64. 10.1016\/j.rmed.2015.01.004","journal-title":"Respir Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2018.09.115","article-title":"Heart-lung transplantation: current indications, prognosis and specific considerations","volume":"10","author":"Le Pavec J","year":"2018","unstructured":"Le Pavec J, Hasco\u00ebt S, Fadel E. Heart-lung transplantation: current indications, prognosis and specific considerations. J Thorac Dis. 2018, 10:5946-52. 10.21037\/jtd.2018.09.115","journal-title":"J Thorac Dis"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.12628","article-title":"Heart-lung vs. double-lung transplantation for idiopathic pulmonary arterial hypertension","volume":"29","author":"Hill C","year":"2015","unstructured":"Hill C, Maxwell B, Boulate D, et al.. Heart-lung vs. double-lung transplantation for idiopathic pulmonary arterial hypertension. Clin Transplant. 2015, 29:1067-75. 10.1111\/ctr.12628","journal-title":"Clin Transplant"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-1227","article-title":"Atrial septostomy in treatment of end-stage right heart failure in patients with pulmonary hypertension","volume":"131","author":"Kurzyna M","year":"2007","unstructured":"Kurzyna M, Dabrowski M, Bielecki D, et al.. Atrial septostomy in treatment of end-stage right heart failure in patients with pulmonary hypertension. Chest. 2007, 131:977-83. 10.1378\/chest.06-1227","journal-title":"Chest"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/111033-management-of-idiopathic-pulmonary-arterial-hypertension-in-a-patient-in-trinidad-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:48:22Z","timestamp":1707508102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/111033-management-of-idiopathic-pulmonary-arterial-hypertension-in-a-patient-in-trinidad-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,28]]},"references-count":36,"URL":"https:\/\/doi.org\/10.7759\/cureus.29699","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,28]]}}}